340724 - Brain Food Data - Home Page Hero 1440x700px

Data: your company’s hidden asset

How to identify, protect and exploit the data you already have

Read more

Today's top story

Cell and gene therapies: resilience the aim in 2023 amidst regulatory flux

Diversification, collaboration and consolidation are likely to be emerging themes in the cell and gene therapies (CGTs) market globally in 2023 and beyond, as developers seek to make their businesses resilient to the economic headwinds they face.

Life Sciences & Health

 

Latest press releases

Show me all press releases

Pinsent Masons advises PIC on £132m buy-in of Tomkins 2008 pension scheme retirement benefits plan

Pinsent Masons advises PIC on £132m buy-in of Tomkins 2008 pension scheme retirement benefits plan.

Pinsent Masons advises on Umicore’s € 591 million sustainability linked note fundraising

Multinational law firm Pinsent Masons has advised various institutional investors in relation to Umicore’s € 591 million sustainability linked note fundraising.

Pinsent Masons advises Alveo on its sale to Symphony Technology Group

Pinsent Masons has advised the shareholders of Alveo, including funds managed by Sovereign Capital Partners (SCP), on its sale to Symphony Technology Group (STG).

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.